Clinical Trials
- Alzheimer's
A Phase 3b/4 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Verify the Clinical Benefit of Aducanumab (BIIB037) in Participants With Alzheimer's Disease (ENVISION)
- Ages60 years - 85 years
- GenderBoth
- Alzheimer's
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease
- Ages50 years - 85 years
- GenderBoth
- Alzheimer's
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. (DIAN-TU)
- Ages18 years - 80 years
- GenderBoth
- Alzheimer's
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid
- Ages55 years - 80 years
- GenderBoth
- Mental Health & Behavioral Research, Alzheimer's
Ketamine for the Treatment of Depression in Parkinson's Disease
- Ages40 years - 70 years
- GenderBoth